Results 161 to 170 of about 8,921 (227)

Complications Associated with Lysergic Acid Diethylamide (LSD-25)

JAMA: The Journal of the American Medical Association, 1962
TWO DECADES AGO Hofmann ' accidentally discovered the hallucinogenic activity of d-lysergic acid diethylamide (LSD-25). Its ability to induce a "model psychosis" makes it an excellent laboratory device for the study of psychotic-like phenomena. LSD-25 has also been employed as an adjunct to psychotherapy because recall of repressed memories is enhanced
S, COHEN, K S, DITMAN
openaire   +2 more sources

LSD (lysergic acid diethylamide)

LSD is a potent hallucinogen. It was first synthesised in 1938. It is marketed under numerous names. Ergot, a fungus that develops on rye and grains, is used to make LSD. The effect of LSD is mind-altering, pleasurable, and stimulating. Sometimes, exposure to this drug causes so-called unpleasant experiences, such as “bad trips”.
Cory C. Howard, Christine M. Stork
openaire   +2 more sources

Lysergic acid diethylamide (LSD-25) and chromosome breaks

Human Genetics, 1968
Chromosomes were studied in 32 non-LSD-using controls (Group I), nine psychiatric patients treated with LSD (Group IIa), and a young married couple, both of whom had taken LSD, and their child (Group IIb). The incidence of chromosomal breaks in Groups IIa and IIb was significantly higher than that of Control Group I.
G, Abbo, A, Norris, H, Zellweger
openaire   +2 more sources

Genetic toxicology of lysergic acid diethylamide (LSD-25)

Mutation Research/Reviews in Genetic Toxicology, 1977
The acute and the chronic psychotomimetic potentials of the hallucinogen lysergic acid diethylamide (LSD-25) have been recognized for almost 40 years. That additional types of the biological effects should have come under scrutiny was directly attributable to widespread use and abuse of this drug on a world-wide basis.
M M, Cohen, Y, Shiloh
openaire   +2 more sources

Progression of Effects of Lysergic Acid Diethylamide [LSD]

Archives of Neurology And Psychiatry, 1956
Introduction Since the Swiss chemist Hoffman, on April 16, 1943, accidentally discovered the mental effects of lysergic acid diethylamide (LSD-25), a great many experiments with the drug have been reported in various journals. Observations show most agreement in the area of physical subjective symptoms and unreality and least agreement in changes of ...
S, SALVATORE, R W, HYDE
openaire   +2 more sources

Lysergic Acid Diethylamide (LSD): No Teratogenicity in Rats

Science, 1968
Lysergic acid diethylamide (LSD) in doses of 1.5 to 300 micrograms was given to 55 pregnant rats during periods of organogenesis and on the 4th or 5th day of pregnancy to 34 rats. Examination of the resultant 887 young for congenital defects showed no greater frequency than in controls. These experiments failed to prove that LSD is teratogenic in rats.
J, Warkany, E, Takacs
openaire   +2 more sources